U.S. judge tosses $150 million verdict against AbbVie in AndroGel case
(Reuters) - A U.S. judge on Friday overturned a $150 million verdict against AbbVie Inc in the first federal court case to go to trial over claims that the company fraudulently misrepresented the risks of its testosterone replacement drug AndroGel.
from Reuters: Health News http://reut.rs/2BRn3Wn
http://bit.ly/2zwRqiM